Feedstuffs is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Phibro logo.jpg

Phibro Animal Health acquires KoVax fish vaccine business

Aquaculture acquisition to create vaccine innovation powerhouse.

Phibro Animal Health Corp. announced Dec. 6 it has acquired the assets of KoVax Ltd., an Israel-based developer and manufacturer of vaccines for the global aquaculture market.

The acquisition strengthens Phibro's position in fish vaccine innovation and expands its portfolio of aquaculture products, the company noted in its announcement. Terms of the deal were not disclosed.

KoVax's research and development (R&D) team has joined Phibro's biological R&D team and will focus on developing a pipeline of innovative vaccines for the aquaculture market, Phibro said, noting that its first commercial aquaculture vaccine is KoVax's "KV3" vaccine, which helps prevent Koi Herpes Virus, a highly contagious disease that can cause significant mortality in common carp farms.

"Phibro strives to be a trusted partner to veterinarians and producers, helping them care for their animals and produce healthy, affordable food. We are excited to welcome the team of talented, dedicated and respected KoVax researchers to Phibro — a place where every individual can make a real impact," Phibro vice president of aquaculture Dr. Raanan Ariav said. "The acquisition of KoVax's strong vaccine portfolio, including KV3 and products currently in development, will empower Phibro to provide our customers with customized solutions to meet their unique challenges."

Orit Kotler, who co-founded KoVax with her husband Yaniv, noted the new opportunities that will come with the acquisition, saying, "I am extremely proud that the years of hard work and creativity our team has brought to developing aquaculture vaccines is recognized by a leading animal health company like Phibro. I am very confident that my team will quickly find themselves at home within the Phibro organization and thrilled with the opportunities to expand the pace and range of their development work. This is a win for aquaculture innovation and fish health."

Ariav added, "Phibro Aqua is on the move with the launch of several successful nutritional products in the past year and a major investment to build up our technical support team. We are now well-positioned to deliver outstanding products and unmatched support services to our global aquaculture customers, and we have no intention of slowing down."

Phibro is a diversified global developer, manufacturer and supplier of a broad range of animal health and mineral nutrition products for livestock, helping veterinarians and farmers produce healthy, affordable food while using fewer natural resources.

TAGS: Business
Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.